The electronic transmission of ICSRs is a key element in improving the process of adverse reaction reporting in pharmacovigilance. It is not only a major step forward in providing information more rapidly but also in standardizing the way clinical safety data elements are presented, thereby improving the collective ability to evaluate complex data.
This programme will address the latest status in the EEA regarding the electronic reporting initiatives from Regulator and Industry perspectives. The special areas that will be covered in depth are:
Panel discussions will provide the opportunity for extensive Q&As with the experts.
This programme will address the latest status in the EEA regarding the electronic reporting initiatives from Regulator and Industry perspectives. The special areas that will be covered in depth are:
Panel discussions will provide the opportunity for extensive Q&As with the experts.
